ISMP Alerts

Packaging Could Lead to Acetaminophen Overdoses


Misleading acetaminophen liquid packaging could lead to acetaminophen overdoses. Caution is advised regarding labeling and packaging of acetaminophen liquid products now on store shelves at several leading chain pharmacies.  CVS, Walgreen, Walmart and likely other chain pharmacies are currently selling 240 mL bottles of the product with labels that fail to indicate product strength. While the label states “500 mg,” no volume is listed to help users recognize the product strength is 500 mg in 15 mL (the equivalent of approximately one tablespoonful).  At the same time, an accompanying dosing cup is only marked 30 mL, which is 1 gram, not 500 mg. Information about the proper strength and dose is printed in the accompanying drug facts panel. However, unless the drug facts label on back of the container is peeled open, this important information will be missed.  Thus, it is possible that consumers may be misled into double dosing - a 2 g dose if the user believes 30 mL marks a 500 mg dose. 

ISMP has interacted with FDA and Walmart about this misleading labeling. The product should be recalled, given the risk of double dosing up to 8 grams per day at the suggested frequency of every 6 hours.

More Alerts

ISMP has received reports from two different hospitals about McKesson packaged levetiracetam 250 unit dose blister packages that have a barcode that scans as naproxen 500 mg. Apparently one side of the unit dose blister of 10 levetiracetam tablets scans properly, but the barcode on other side
URGENT – HAZARDOUS SITUATION – PLEASE REACT IMMEDIATELY ISMP is aware of an extremely hazardous packaging error involving certain cisatracurium products from Meitheal Pharmaceuticals. While the outer carton identifies the vials inside as cisatracurium, the vials contained in the carton are labeled
We recently learned about three cases of accidental spinal injection of tranexamic acid instead of a local anesthetic intended for regional (spinal) anesthesia. Container mix-ups were involved in each case. In one case, a patient scheduled for knee surgery received tranexamic acid instead of